Home Carboxes 100986-85-4
100986-85-4,MFCD00865049
Catalog No.:AA0003AY
100986-85-4 | 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-
Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$44.00   $31.00
- +
5g
98%
in stock  
$65.00   $45.00
- +
25g
98%
in stock  
$182.00   $128.00
- +
100g
98%
in stock  
$362.00   $253.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Q & A
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA0003AY
Chemical Name:
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-
CAS Number:
100986-85-4
Molecular Formula:
C18H20FN3O4
Molecular Weight:
361.3675
MDL Number:
MFCD00865049
IUPAC Name:
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
InChI:
InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1
InChI Key:
GSDSWSVVBLHKDQ-JTQLQIEISA-N
SMILES:
CN1CCN(CC1)c1c(F)cc2c3c1OC[C@@H](n3cc(c2=O)C(=O)O)C
UNII:
RIX4E89Y14
NSC Number:
758709
Properties
Computed Properties
 
Complexity:
634  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
361.144g/mol
Formal Charge:
0
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
361.373g/mol
Monoisotopic Mass:
361.144g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
73.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.4  

Synonyms
 
Anhydrous, Levofloxacin 
Levaquin 
Cravit 
AC1L3YF8 
SCHEMBL15397 
BSPBio_002689 
KBioGR_001605 
KBioSS_002199 
fluoro-methyl-(4-methylpiperazin-1-yl)-oxo-[?]carboxylic acid 
MLS000759524 
MLS001165709 
MLS001423977 
SPECTRUM1504260 
Iquix 
SPBio_001891 
DTXSID0041060 
KBio2_002199 
KBio2_004767 
KBio2_007335 
KBio3_001909 
BIL1009 
EBD8264 
GSDSWSVVBLHKDQ-JTQLQIEISA-N 
ZX-AFC000651 
Levofloxacine 
HMS1922J07 
HMS2051G04 
HMS2090O10 
HMS2093E18 
HMS2232G06 
Pharmakon1600-01504260 
ZINC538273 
BCP22048 
EX-A1488 
HY-B0330 
Tavanic 
Levofloxacin, >=98.0% (HPLC) 
BDBM50366826 
BG0235 
CCG-39093 
DE-108 
MMV687798 
NSC758709 
s1940 
AKOS008901361 
AKOS015895104 
(-)-Ofloxacin 
AC-7593 
AN-8873 
API0007780 
CS-2218 
DB01137 
MCULE-2011834955 
NC00094 
NSC-758709 
NCGC00178529-01 
NCGC00178529-03 
Ofloxacin S-(-)-form 
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate 
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate 
AJ-23383 
AS-31796 
LVX 
SAM001246758 
Levofloxacin, analytical reference material 
SBI-0206768.P001 
AB0072147 
AB1009501 
(S)-Ofloxacin 
LS-133260 
LS-171761 
FT-0627808 
L0193 
ST24047487 
C07660 
D08120 
AB00171657-12 
AB00171657-13 
AB00171657_14 
Levofloxacino 
AB00171657_15 
986L854 
SR-05000001999 
Levofloxacin, Antibiotic for Culture Media Use Only 
SR-05000001999-1 
BRD-K09471561-001-06-7 
Z1766089137 
UNII-A4P49JAZ9H component GSDSWSVVBLHKDQ-JTQLQIEISA-N 
Levofloxacin solution, 1.0 mg/mL in acetonitrile, certified reference material 
(-)-Ofloxacin; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid 
Levofloxacinum 
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0;{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid 
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid 
(S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid 
(S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acid 
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hemihydrate, (S)- 
LVFX; RWJ 25213; L-Ofloxacin; Ophthalmic; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid 
ofloxacin 
d-Levofloxacin 
R-Ofloxacin 
Floxin 
Elequine 
Not Available 
FLUOROQUINOLONE 
Levofloxacin Anhydrous 
Oftaquix (TN) 
Tavanic (TN) 
Quixin (TN) 
Levofloxacin Hemihydrate 
Iquix (TN) 
Anhydrous, Levofloxacin 
Ofloxacin, (S)-Isomer 
Levofloxacin 
Oftaquix 
CHEMBL33 
D02RSN 
DR 3354 
Levofloxacin, 98% - 25G 25g 
C18-H20-F-N3-O4 
CID149096 
ACN-038325 
CS-O-01741 
A5511 
B1959 
L-Ofloxacin 
D064704 
(S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid 
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid 
82419-36-1 
Floxacin 
(S)-(-)-Ofloxacin 
DR-3355 
Levofloxacine [INN-French] 
Levofloxacinum [INN-Latin] 
Levofloxacino [INN-Spanish] 
DR3355 
HR 355 
Levofloxacin Anhydrous 
Levofloxacin [USAN:INN:JAN] 
Levofloxacin hydrate 
RWJ 25213-097 
UNII-RIX4E89Y14 
MP-376 
RWJ-25213 
CCRIS 4074 
Levofloxacin (Levaquin) 
Levaquin (TN) 
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER 
Ofloxacin, (S)-Isomer 
RIX4E89Y14 
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid 
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid 
CHEBI:63598 
CPD000466387 
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid 
(S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid 
LFX 
Q-201295 
Aeroquin 
Quixin 
Leroxacin 
Lesacin 
Levokacin 
Levoxacin 
Mosardal 
Nofaxin 
Reskuin 
Unibiotic 
Venaxan 
Volequin 
LEVOFLOXACIN 
Floxel 
Levox 
Loxof 
138199-71-0 
Cravit Ophthalmic 
C18H20FN3O4.H2O 
()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1;()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1 
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid 
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)- 
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)- 
100986-85-4 
SMR000466387 
(R)-isomer 
Cravit (TN) 
Levofloxacin (INN) 
S-(-)-Ofloxacin 
CCRIS 4073 
C18H20FN3O4 
Levofiexacin 
Cravit hydrate 
Iquix hydrate 
Levaquin 
Levaquin hydrate 
Levo Floxacin 
MFCD00865049 
HSDB 8028 
Cravit IV 
Levofloxacin,(S) 
DR-3355: L-isomer of ofloxacin 
(3s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid 
(R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid 
AK163316 
Quixin 
DRG-0129 
levofloxacin-levaquin 
HR-355 
MP 376 
Spectrum_001719 
Spectrum2_001676 
Spectrum3_000995 
Spectrum4_001123 
Spectrum5_001438 
Levofloxacin tablet, suspension or intravenous 
Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Additional Info:
Q & A